Adaptimmune Limited

Focusing on the needs of our patients

Learn More

Enhancing the Affinity of T-cell to Fight Cancer

Learn More

Investigating SPEAR T-Cell Therapy in 10 Solid Tumors

Learn More

Working with Leading Experts to Transform T-cell Therapy for Cancer Patients

Learn More

Latest News • View all

February 7, 2019
Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019
January 7, 2019
Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews
December 12, 2018
Adaptimmune Announces that Gwen Binder will leave in January 2019

Adaptimmune on Linkedin linkedin

Adaptimmune on Twitter

The Immune System
The Immune System
Clinical Trials
Clinical Trials
Our Pipeline
Our Pipeline
Manufacturing
Manufacturing
Partnerships
Partnerships